The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
Open accessAbstract
Dormant solid tumors were produced in vivo by prevention of neovascularization. When small fragments of anaplastic Brown-Pearce carcinoma were implanted directly on the iris in susceptible rabbits, they always vascularized. A characteristic growth pattern, consisting of prevascular, vascular, and late phases, was observed, which terminated with destruction of the eye within 2 wk. The beginning of exponential volume increase was shown to coincide with vascularization of the implant, as demonstrated by perfusion with intravenous fluorescein and by histologic sections. In contrast, implants placed in the anterior chamber, at a distance from the iris, did not become vascularized. After initial growth into spheroids, they remained arrested at a small size comparable to prevascular iris implants, for periods as long as 6 wk. Although dormant in terms of expansion, these avascular tumors contained a population of viable and mitotically active tumor cells. When reimplanted on the iris, vascularization was followed by rapid, invasive growth. These observations suggest that neovascularization is a necessary condition for malignant growth of a solid tumor. When a small mass of tumor cells is prevented from eliciting new vessel ingrowth from surrounding host tissues, population dormancy results. These data suggest that the specific blockade of tumor-induced angiogenesis may be an effective means of controlling neoplastic growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Self-citationIsolation of a tumor factor responsible for angiogenesis
Folkman, J., Merler, E., Abernathy, C., & Williams, G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.2.275 · Cited by 1,663
Self-citationAnti-Angiogenesis: New Concept for Therapy of Solid Tumors
Folkman, J. (1972) · Annals of Surgery · doi:10.1097/00000658-197203000-00014 · Cited by 1,171
Self-citationPreservation of Vascular Integrity in Organs perfused in vitro with a Platelet-rich Medium
GIMBRONE, M. A., ASTER, R. H., COTRAN, R. S., CORKERY, J., JANDL, J. H., & FOLKMAN, J. (1969) · Nature · doi:10.1038/222033a0 · Cited by 257
Self-citationFOLKMAN, J., COLE, P., & ZIMMERMAN, S. (1966) · Annals of Surgery · doi:10.1097/00000658-196609000-00012 · Cited by 247
Self-citationHadfield, G. (1954) · BMJ · doi:10.1136/bmj.2.4888.607 · Cited by 215
Experimental Evidence in Support of the Dormant Tumor Cell
Fisher, B., & Fisher, E. R. (1959) · Science · doi:10.1126/science.130.3380.918 · Cited by 174
HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS
Greene, H. S. N. (1941) · The Journal of Experimental Medicine · doi:10.1084/jem.73.4.461 · Cited by 156
HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS
Greene, H. S. N. (1941) · The Journal of Experimental Medicine · doi:10.1084/jem.73.4.475 · Cited by 76
Cited by
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Self-citationWhat Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Self-citationFolkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Self-citationFolkman, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131306 · Cited by 1,209
Self-citation(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60946-x · Cited by 1,071
Folkman, J., & Haudenschild, C. (1980) · Nature · doi:10.1038/288551a0 · Cited by 1,037
Self-citationCirculating Tumor Cells in Patients with Breast Cancer Dormancy
Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1110 · Cited by 971
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
SELF-REGULATION OF GROWTH IN THREE DIMENSIONS
Folkman, J., & Hochberg, M. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.138.4.745 · Cited by 829
Self-citationCXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
The Biology of Cancer Invasion and Metastasis
(1978) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60648-x · Cited by 801
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Zhao, Y., Hu, X., Liu, Y., Dong, S., Wen, Z., He, W., Zhang, S., Huang, Q., & Shi, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0648-1 · Cited by 735
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
Angiogenesis Assays: A Critical Overview
Auerbach, R., Lewis, R., Shinners, B., Kubai, L., & Akhtar, N. (2003) · Clinical Chemistry · doi:10.1373/49.1.32 · Cited by 705
Growth factors in development, transformation, and tumorigenesis
Cross, M., & Dexter, T. M. (1991) · Cell · doi:10.1016/0092-8674(91)90638-f · Cited by 694
Metronomic chemotherapy: new rationale for new directions
Pasquier, E., Kavallaris, M., & André, N. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.82 · Cited by 659
Gerber, H.-P., & Ferrara, N. (2005) · Cancer Research · doi:10.1158/0008-5472.671.65.3 · Cited by 626
Rørth, P. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113231 · Cited by 599
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597
Protamine is an inhibitor of angiogenesis
Taylor, S., & Folkman, J. (1982) · Nature · doi:10.1038/297307a0 · Cited by 580
Self-citationThe dormant cancer cell life cycle
Phan, T. G., & Croucher, P. I. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0263-0 · Cited by 576
Nicolson, G. L. (1982) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(82)90020-8 · Cited by 560
A history of exploring cancer in context
Maman, S., & Witz, I. P. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0006-7 · Cited by 502
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510
Microvessel density is a prognostic indicator for patients with astroglial brain tumors
Leon, S. P., Folkerth, R. D., & Black, P. M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<362::aid-cncr20>3.0.co;2-z · Cited by 481
(1974) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60058-5 · Cited by 477
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M. (2000) · Blood · doi:10.1182/blood.v95.8.2637 · Cited by 476
Mast cell heparin stimulates migration of capillary endothelial cells in vitro.
Azizkhan, R. G., Azizkhan, J. C., Zetter, B. R., & Folkman, J. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.4.931 · Cited by 441
Self-citationKerbel, R. S. (1991) · BioEssays · doi:10.1002/bies.950130106 · Cited by 441
Wolfram, J., & Ferrari, M. (2019) · Nano Today · doi:10.1016/j.nantod.2019.02.005 · Cited by 436
Multicellular spheroids: A review on cellular aggregates in cancer research
Mueller-Klieser, W. (1987) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00391431 · Cited by 434
Geiger, T. R., & Peeper, D. S. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.07.006 · Cited by 431
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype
Naumov, G. N., Bender, E., Zurakowski, D., Kang, S.-Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj068 · Cited by 423
Self-citationGriffith, E. C., Su, Z., Turk, B. E., Chen, S., Chang, Y.-H., Wu, Z., Biemann, K., & Liu, J. O. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90198-8 · Cited by 421
Halting angiogenesis suppresses carcinoma cell invasion
Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S., & Fusenig, N. E. (1997) · Nature Medicine · doi:10.1038/nm1197-1222 · Cited by 420
Folkman, J. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00133-5 · Cited by 415
Self-citationInhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., & Strieter, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118734 · Cited by 403
Quantitative angiogenesis assays: Progress and problems
Jain, R. K., Schlenger, K., Hockel, M., & Yuan, F. (1997) · Nature Medicine · doi:10.1038/nm1197-1203 · Cited by 385
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
Inhibition of tumor angiogenesis mediated by cartilage.
Brem, H., & Folkman, J. (1975) · The Journal of experimental medicine · doi:10.1084/jem.141.2.427 · Cited by 359
Self-citationArenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.981 · Cited by 353
VEGF-A: a critical regulator of blood vessel growth
Ferrara, N. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0170 · Cited by 327
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
Qin, S., Li, A., Yi, M., Yu, S., Zhang, M., & Wu, K. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0718-5 · Cited by 324
Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer
Gasparini, G. (2000) · The Oncologist · doi:10.1634/theoncologist.5-2004-37 · Cited by 322
Angiogenesis inhibition: A review
Auerbach, W., & Auerbach, R. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90027-2 · Cited by 321
Metastasis prevention by targeting the dormant niche
Ghajar, C. M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3910 · Cited by 320
Yang, E. V., Kim, S.-J., Donovan, E. L., Chen, M., Gross, A. C., Webster Marketon, J. I., Barsky, S. H., & Glaser, R. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.10.005 · Cited by 317
A review of the development of tumor vasculature and its effects on the tumor microenvironment
Forster, J., Harriss-Phillips, W., Douglass, M., & Bezak, E. (2017) · Hypoxia · doi:10.2147/hp.s133231 · Cited by 313
Pathways mediating VEGF-independent tumor angiogenesis
Ferrara, N. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.003 · Cited by 313
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60942-2 · Cited by 289
The impact of VEGF on cancer metastasis and systemic disease
Yang, Y., & Cao, Y. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.011 · Cited by 286
Chesney, J., Metz, C., Bacher, M., Peng, T., Meinhardt, A., & Bucala, R. (1999) · Molecular Medicine · doi:10.1007/bf03402061 · Cited by 284
Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.
Sidky, Y. A., & Auerbach, R. (1975) · The Journal of experimental medicine · doi:10.1084/jem.141.5.1084 · Cited by 281
Tumor Angiogenesis: A Possible Control Point in Tumor Growth
FOLKMAN, J. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-1-96 · Cited by 278
Self-citationAdaptation to hypoxia and acidosis in carcinogenesis and tumor progression
Fang, J. S., Gillies, R. D., & Gatenby, R. A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.011 · Cited by 277
Angiogenesis in myelodysplastic syndromes
Pruneri, G., Bertolini, F., Soligo, D., Carboni, N., Cortelezzi, A., Ferrucci, P. F., Buffa, R., Lambertenghi-Deliliers, G., & Pezzella, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6693515 · Cited by 271
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
STEIN, J. P., GROSSFELD, G. D., GINSBERG, D. A., ESRIG, D., FREEMAN, J. A., FIGUEROA, A. J., SKINNER, D. G., & COTE, R. J. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62747-2 · Cited by 271
The Pathophysiology of Angiogenesis
Polverini, P. J. (1995) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411950060030501 · Cited by 267
Lymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide?
Wong, S. Y., & Hynes, R. O. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2646 · Cited by 266
Mast cells and tumor angiogenesis
Kessler, D. A., Langer, R. S., Pless, N. A., & Folkman, J. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910180520 · Cited by 265
Self-citationGriffith, E. C., Su, Z., Niwayama, S., Ramsay, C. A., Chang, Y.-H., & Liu, J. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15183 · Cited by 262
ANGIOGENESIS: INITIATION AND CONTROL*
Folkman, J. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb25720.x · Cited by 262
Self-citationArenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Morris, S. B., Xue, Y. Y., Burdick, M. D., Glass, M. C., Iannettoni, M. D., & Strieter, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3145 · Cited by 259
Cell surface molecules and tumor metastasis
Nicolson, G. L. (1984) · Experimental Cell Research · doi:10.1016/0014-4827(84)90696-7 · Cited by 259
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype
Almog, N., Ma, L., Raychowdhury, R., Schwager, C., Erber, R., Short, S., Hlatky, L., Vajkoczy, P., Huber, P. E., Folkman, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2590 · Cited by 240
Self-citationWagner, M., Bjerkvig, R., Wiig, H., Melero-Martin, J. M., Lin, R.-Z., Klagsbrun, M., & Dudley, A. C. (2012) · Angiogenesis · doi:10.1007/s10456-012-9276-y · Cited by 91
Parham, K. A., Zebol, J. R., Tooley, K. L., Sun, W. Y., Moldenhauer, L. M., Cockshell, M. P., Gliddon, B. L., Moretti, P. A., Tigyi, G., Pitson, S. M., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-261289 · Cited by 89
Arenberg, D., White, E., Burdick, M., Strom, S., & Strieter, R. (2001) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-001-0231-9 · Cited by 73
(1984) · PubMed · Cited by 53
Metadata
- Authors
- Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1972-08-01
- Volume
- 136
- Issue
- 2
- Pages
- 261-276
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2146916102
- Cited by
- 903
- References
- 9
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.